MyFinsight
Home
Compare
About
Recent SEC Filings
10/2
NIKE, Inc.
(NKE)
10/2
DARDEN RESTAURANTS INC
(DRI)
9/30
CONAGRA BRANDS INC.
(CAG)
9/29
Carnival Corp Ltd.
(CCL)
9/29
URANIUM ENERGY CORP
(UEC)
9/29
COPART INC
(CPRT)
9/24
BLACKBERRY Ltd
(BB)
9/24
PAYCHEX INC
(PAYX)
9/23
GENERAL MILLS INC
(GIS)
9/22
ADOBE INC.
(ADBE)
9/18
KROGER CO
(KR)
10/2
NIKE, Inc.
(NKE)
10/2
DARDEN RESTAURANTS INC
(DRI)
9/30
CONAGRA BRANDS INC.
(CAG)
9/29
Carnival Corp Ltd.
(CCL)
9/29
URANIUM ENERGY CORP
(UEC)
9/29
COPART INC
(CPRT)
9/24
BLACKBERRY Ltd
(BB)
9/24
PAYCHEX INC
(PAYX)
9/23
GENERAL MILLS INC
(GIS)
9/22
ADOBE INC.
(ADBE)
9/18
KROGER CO
(KR)
Income Statement
|
Cash Flow
|
Balance Sheet
|
Ratios
|
Compare
Cash Flow Overview
Unit: Dollar
Positive Cash Flow Breakdown
Prepaid expenses and other
Share-based expense
Negative Cash Flow Breakdown
Net loss
Accounts payable, accrued expens...
Subscribe for Financial Insights
Page 1
Quarterly
123
Page 1
Cash Flow
2026-06-30
2026-03-31
2025-12-31
2025-09-30
Net loss
-929,695
-456,382
-579,076
-509,940
Share-based expense
51,964
11,312
13,998
50,789
Prepaid expenses and other
-65,504
81,521
-780,067
524,407
Other assets
0
-
313,921
0
Accounts payable, accrued expenses and other liabilities
-63,262
-9,786
-143,750
208,345
Net cash used in operating activities
-875,489
-536,377
-242,682
-658,247
Net proceeds from issuance of common stock in october 2025 underwritten public offering
-
-
4,004,715
-
Net cash provided by financing activities
-
-
4,004,715
-
Net change in cash
-875,489
-536,377
3,762,033
-658,247
Cash at beginning of period
7,347,255
7,883,632
4,121,599
6,165,568
Cash at end of period
6,471,766
7,347,255
7,883,632
4,121,599
Page 1
Unit: Dollar. Numbers labeled with * are estimated quarterly values.
Page 1
Buy us a coffee
Time Plot
Show the time plot by selecting a row from the table.
Cash Flow
XBIO Cash Flow Sankey Diagram
Sankey diagram visualizing XBIO cash flow for the period
Net change in cash
-$875,489
(36.82%↑ Y/Y)
Prepaid expenses and
other
-$65,504
(-143.12%↓ Y/Y)
Share-based expense
$51,964
(48.75%↑ Y/Y)
Net cash used in
operating activities
-$875,489
(36.82%↑ Y/Y)
Canceled cashflow
$117,468
Net loss
-$929,695
(41.60%↑ Y/Y)
Accounts payable,
accrued expenses and...
-$63,262
(-790.11%↓ Y/Y)
Buy us a coffee
Xenetic Biosciences, Inc. (XBIO)
Xenetic Biosciences, Inc. (XBIO)